Clinical Trial Update: Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral colchicine combined with intravitreal dexamethasone, low molecular weight heparin, and 5-fluorouracil for proliferative vitreoreti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy

Drugs mentioned

• 5-Fluorouracil (5-FU)
• COLCHICINE (Colchicine)
• DEXAMETHASONE (Dexamethasone)
• Enoxaparin sodium (Enoxaparin sodium)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Proliferative Vitreoretinopathy | Phase 3 | Status: UNKNOWN